According to the Zhitong Finance APP, recently, FTSE Russell updated the semi-annual adjustment list for the FTSE Global Equity Index Series for September. In the Hong Kong stock sector, CHIFENG GOLD (06693) and LAOPU GOLD (06181) were included in the FTSE China Large Cap Index, while 11 Hong Kong stocks, including SF INTRA-CITY (09699), ROBOSENSE (02498), Fourth Paradigm (06682), and HeYu-B (02256), were included in the FTSE China Small Cap Index. The related adjustments will officially take effect after the market closes on September 19.
As one of the leaders in the global index industry, FTSE Russell has long provided innovative benchmarks, analytics, and data solutions for global investors. Currently, approximately $20 trillion in assets are benchmarked to FTSE Russell indices, and its products are widely adopted by global institutions and individual investors.
The FTSE Global Equity Index Series categorizes constituent stocks into four market capitalization tiers based on free float market capitalization (excluding strategic holdings, restricted shares, and other non-freely traded portions), including large-cap, mid-cap, small-cap, and micro-cap stocks.
In this adjustment, the FTSE China Large Cap Index included 9 Hong Kong stocks with large market capitalization, high liquidity, and concentrated industry leaders. CHIFENG GOLD and LAOPU GOLD are included for the first time, while 3SBio (01530), China Ruyi (00136), Meitu (01357), NetEase Cloud Music (09899), Rongchang Bio (09995), Fudan University (01385), and Sunshine Insurance (06963) were all scale adjustments moving up from mid-cap or small-cap.
In terms of mid-cap stocks, 1 Hong Kong stock was included, namely Xinyi Solar (00968), which was downgraded from large-cap. Small-cap stocks included 14 Hong Kong stocks, among which HeYu-B, Fourth Paradigm, SF INTRA-CITY, Health Road (02587), Jiufang Zhitu Holdings (09636), ROBOSENSE, Shangmei Co., Ltd. (02145), WanGuo Gold Group (03939), WeLong Delicious (09985), JingTai Holdings (02228), and Yixin Group (02858) are all newly included targets; Kejia Pharmaceutical-B (02171), Genting New Vision (01952), and JiaHua International (00173) were company territorial corrections, changing from the Hong Kong region to the China region.
From this adjustment of the FTSE Russell index series components, it can be seen that the newly selected stocks exhibit two particularly prominent commonalities: first, most have recorded significant gains this year, with performance clearly outperforming the market, demonstrating outstanding phase performance; second, these companies mostly belong to clearly defined growth attributes and vibrant industries, reflecting the index's precise identification and forward-looking layout for high prosperity sectors.
In terms of market performance, the 9 stocks included this time have all achieved considerable increases this year, supported by the high prosperity of their respective industries. Specifically, the continuous rise in international gold prices has driven the gold sector collectively upward, with CHIFENG GOLD rising over 120% this year; the new consumption track continues to heat up, with LAOPU GOLD becoming a market focus with over 200% increase; the biopharmaceutical sector is also undergoing a value reassessment, with strong performance in sub-sectors such as innovative drugs, CXO, and medical devices, with multiple stocks doubling in price
Among them, Rongchang Biologics has surged nearly 670% this year, and the market capitalization of 3SBio has also surpassed HKD 77 billion.
Inclusion in international indices usually means broader capital attention and liquidity premiums. With passive capital allocation such as index funds, the company is expected to attract more incremental funds, enhance trading activity, and provide more support for its stock price. The endorsement from FTSE Russell will also enhance its visibility and credibility in the global market, laying the foundation for attracting quality capital and expanding cooperation, thus aiding long-term value release.
Related Concept Stocks:
CHIFENG GOLD (06693): A mining company focused on gold mining and comprehensive resource recovery. In the first half of 2025, CHIFENG GOLD's net profit attributable to the parent company soared to RMB 1.107 billion, a year-on-year increase of 55.79%. Despite facing challenges such as rising production costs, the bullish trend in gold prices is expected to continue against the backdrop of the Federal Reserve's interest rate cut cycle and geopolitical risks, making the company's performance elasticity worth looking forward to.
LAOPU GOLD (06181): Listed on the Hong Kong Stock Exchange on June 28, 2024, its stock price has skyrocketed post-listing, becoming a &#34;new star&#34; in the gold retail sector. Its stock price has accumulated a rise of 204.65% this year, and its performance since listing has been even more impressive, soaring 17.14 times from the issue price, surpassing Tencent Holdings to become the highest-priced stock in the Hong Kong market.
SF INTRA-CITY (09699): As the largest third-party instant delivery platform in China, SF INTRA-CITY has seen steady increases in market capitalization and liquidity since its listing in December 2021. Relying on its rare independent third-party positioning and all-scenario business model, it has become an important infrastructure for the development of instant retail, solidifying its leading position in the industry. Daiwa recently released a research report, maintaining a target price of HKD 20 for SF INTRA-CITY, reiterating a &#34;Buy&#34; rating, and raising its earnings per share forecast for SF INTRA-CITY for 2025-2027 by 6-7%, reflecting better-than-expected revenue prospects.
3SBio (01530): A high-tech enterprise integrating the research, production, and sales of biopharmaceuticals. In May of this year, 3SBio attracted market attention due to a massive business development agreement signed with Pfizer. Recently, its market capitalization surpassed HKD 77 billion, reaching a new high since its listing, with a market capitalization increase of over HKD 63.5 billion this year.
Fourth Paradigm (06682): Recently, several well-known brokerages have raised their target prices for Fourth Paradigm, unanimously optimistic about this AI pioneer’s growth potential and unique value in the &#34;Artificial Intelligence +&#34; era. CMB International raised Fourth Paradigm's target price from HKD 64 to HKD 81, maintaining a &#34;Buy&#34; rating. Daiwa believes that Fourth Paradigm has a solid position in the AI field and will benefit from the &#34;AI+&#34; development trend, raising the company's target price from HKD 58 to HKD 74

600988

06181

09699

02498

YINN

YANG

In the adjustments that will officially take effect after the market closes on September 19, FTSE Russell has included CHIFENG GOLD and LAOPU GOLD in the FTSE China Large Cap Index, while 11 Hong Kong stocks, including SF INTRA-CITY and ROBOSENSE, have been included in the FTSE China Small Cap Index. This adjustment reflects the market's focus on high liquidity and industry-leading companies

Zhitong

CHIFENG GOLD

LAOPU GOLD

SF INTRA-CITY

ROBOSENSE

Direxion FTSE China Bull 3X

Direxion FTSE China Bear 3X

Hong Kong Stock Concept Tracking | FTSE Russell Index Adjustment is About to Take Effect! Multiple Strong Stocks Lead the New Growth Cycle (Including Concept Stocks)